Sol de Janeiro vs Trilogy:Which is searched more?
In September 2026, Sol de Janeiro had more branded searches than Trilogy among body care brands worldwide. Sol de Janeiro had about 1.2 million branded searches, while Trilogy had 135,000. Sol de Janeiro made up 17.1% of all body care brand searches we track, and Trilogy accounted for 1.9%. These are worldwide searches for English-language branded terms.
Follow Sol de Janeiro vs Trilogy and get free monthly updates on what changed
By continuing you'll get index updates and occasional product news from Brandwave. Unsubscribe any time. Privacy
Is Sol de Janeiro or Trilogy more popular in search?
Compare the body lotion, oil and body care brands people buy. Branded searches tell you how often people look for a brand by name or related terms. Comparing these searches across competitors helps you see how popular each brand is over time.
Share of searches by month for Sol de Janeiro, Trilogy. The figures are in the table below the chart.
View monthly share of searches table
| Month | La Roche-Posay | Vaseline | CeraVe | Sol de Janeiro | Bio-Oil | Aveeno | Trilogy | Naturium | Palmer's |
|---|---|---|---|---|---|---|---|---|---|
| Oct 2025 | 22.8% | 17% | 22.8% | 22.8% | 5.6% | 4.1% | 2.1% | 1.7% | 1.1% |
| Nov 2025 | 21.3% | 18.2% | 17.4% | 31.8% | 4.3% | 3.4% | 1.3% | 1.6% | 0.86% |
| Dec 2025 | 20.2% | 15.7% | 16.5% | 36.9% | 4.1% | 3.4% | 1.2% | 1.2% | 0.82% |
| Jan 2026 | 25.6% | 18.6% | 21% | 21% | 5.2% | 4.3% | 1.9% | 1.5% | 1% |
| Feb 2026 | 28.1% | 16.5% | 22.9% | 18.8% | 5.6% | 3.9% | 1.7% | 1.4% | 1.1% |
| Mar 2026 | 30.9% | 14.7% | 20.6% | 20.6% | 5.1% | 4.1% | 1.5% | 1.5% | 1% |
| Apr 2026 | 32.1% | 15.3% | 21.4% | 17.6% | 5.3% | 4.2% | 1.6% | 1.6% | 1.1% |
| May 2026 | 32.9% | 13.1% | 22% | 18% | 5.4% | 3.9% | 1.6% | 2% | 1.1% |
| Jun 2026 | 28.7% | 14% | 23.5% | 19.2% | 5.8% | 4.2% | 1.7% | 1.7% | 1.2% |
| Jul 2026 | 28.5% | 13.8% | 23.2% | 19.1% | 5.7% | 4.3% | 1.7% | 2.6% | 1.1% |
| Aug 2026 | 28.2% | 16.4% | 23.1% | 18.9% | 4.6% | 4.2% | 1.7% | 1.7% | 1.1% |
| Sep 2026 | 25.7% | 21.4% | 21.1% | 17.1% | 5.2% | 4.7% | 1.9% | 1.5% | 1.3% |
How has the Sol de Janeiro and Trilogy comparison changed over the last 12 months?
3 findings
- Sol de Janeiro was ahead of Trilogy in every measured month of the 12 months ending September 2026.
- Across the 12 months ending September 2026, Sol de Janeiro’s share of searches among body care brands worldwide moved from 22.8% to 17.1%, and its estimated monthly branded searches moved from 1.8M to 1.2M.
- Across the 12 months ending September 2026, Trilogy’s share of searches among body care brands worldwide moved from 2.1% to 1.9%, and its estimated monthly branded searches moved from 165K to 135K.
How did search popularity change for body care brands worldwide in September 2026?
3 changes
In September 2026, Vaseline overtook CeraVe and Sol de Janeiro to rank 2nd among body care brands worldwide, with 21.4% of the searches.
In September 2026, Sol de Janeiro lost share of searches among body care brands worldwide, from 18.9% to 17.1%.
In September 2026, Trilogy rose from 8th to 7th among body care brands worldwide.
How are branded searches counted?
2 search terms
Brandwave collects information about searches that people make online using Sol de Janeiro’s and Trilogy’s names. When viewed over time, estimated search volumes for these branded terms can be used to understand whether interest in the brands is growing, holding steady, or fading.
Sol de Janeiro
1 branded search term
- sol de janeiro
Trilogy
1 branded search term
- trilogy
Other head-to-heads among body care brands
La Roche-Posay vs Vaseline: compare search popularity
La Roche-Posay vs CeraVe: compare search popularity- La Roche-Posay vs Sol de Janeiro: compare search popularity
La Roche-Posay vs Bio-Oil: compare search popularity- Vaseline vs CeraVe: compare search popularity
- Vaseline vs Sol de Janeiro: compare search popularity
Put your own brand in this comparison
Brandwave tracks your branded demand next to the rival you actually watch, with your campaigns, spend and outcomes on the same timeline.